Featured Industry Theater
When It Could Be Cystic Fibrosis (CF): Diagnosing CF in People with Atypical Disease Presentation
Innovation Theater 1
Sponsored by Vertex Pharmaceuticals, Inc.
Loading view.
Industry Theater
What Can the Future Hold for Your Patients With Severe Asthma?
Innovation Theater 3
Sponsored by Amgen/AstraZeneca
Featured Industry Theater
Clinical and patient-centered discussions on the role of inflammation in bronchiectasis
Innovation Theater 5
Sponsored by Insmed
Innovation Hub
Silent No More – Uncovering the Role of Small Airways in Asthma
Innovation Hub 3
Sponsored by Chiesi USA
Innovation Hub
Advances in Ventilation and Perfusion (VQ) Assessment in COPD, CTEPH and Other Chronic Pulmonary Vascular Disorders
Innovation Hub 4
Sponsored by 4D Medical
Industry Theater
Should We Be Targeting Eosinophils Regardless of Allergic Status in Patients With Severe Eosinophilic Asthma?
Innovation Theater 2
Sponsored by GSK
Featured Innovation Hub
Elevating Asthma Control: Implications for Your Pediatric Patients
Innovation Hub 1
Sponsored by sanofi | regeneron
Industry Theater
Implementing Treprostinil Induction Strategies in Pulmonary Arterial Hypertension
Innovation Theater 1
Sponsored by United Therapeutics
Innovation Hub
Embracing the Changes: New Horizons in Asthma Clinical Trials
Innovation Hub 4
Sponsored by Parexel
Innovation Hub
How Methapharm Leverages Market Data for Strategic Growth
Innovation Hub 3
Sponsored by AcuityMD
Innovation Hub
EVIS X1 with Prof. Felix Herth, MD
Innovation Hub 1
Sponsored by Olympus America Inc
Industry Theater
A Brief Review of Clinical Insights for Identifying and Managing Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Innovation Theater 2
Sponsored by GSK
Industry Theater
Navigating RSV in Adults: Insights into Disease and Vaccination
Innovation Theater 3
Sponsored by GSK
Industry Theater
How Would You Address Eosinophilic + Allergic Inflammation in Severe Asthma?
Innovation Theater 5
Sponsored by Amgen/AstraZeneca